1,646
Views
40
CrossRef citations to date
0
Altmetric
Reviews

Consumption of coffee or caffeine and serum concentration of inflammatory markers: A systematic review

, , , , &

References

  • Akash, M. S., K. Rehman, and S. Chen. 2014. Effects of coffee on type 2 diabetes mellitus. Nutrition. 30:755–763.
  • Alexopoulos, N., C. Vlachopoulos, K. Aznaouridis, K. Baou, C. Vasiliadou, P. Pietri, P. Xaplanteris, E. Stefanadi, and C. Stefanadis. 2008. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil. 15:300–305.
  • American Diabetes Association. ADA. 2017. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 40:S11–S24.
  • Antonisamy, P., M. V. Arasu, M. Dhanasekaran, K. C. Choi, A. Aravinthan, N. S. Kim, C. W. Kang, and J. H. Kim. 2016. Protective effects of trigonelline against indomethacin-induced gastric ulcer in rats and potential underlying mechanisms. Food Funct. 7:398–408.
  • Bhattacharya, M. 2017. Could a coffee a day keep the inflammasome away? Sci Transl Med. 9.
  • Bidel, S., G. Hu, P. Jousilahti, R. Antikainen, E. Pukkala, T. Hakulinen, and J. Tuomilehto. 2010. Coffee consumption and risk of colorectal cancer. Eur J Clin Nutr. 64:917–923.
  • Bloomer, R. J., T. M. Farney, I. C. Harvey, and R. J. Alleman. 2013. Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men. Hum Exp Toxicol. 32:1126–1136.
  • Cao, Y., G. Wittert, A. W. Taylor, R. Adams, S. Appleton, and Z. Shi. 2016. Nutrient patterns and chronic inflammation in a cohort of community dwelling middle-aged men. Clin Nutr. S0261–5614:30153–30154.
  • Chavez Valdez, R., R. Ahlawat, M. Wills-Karp, A. Nathan, T. Ezell, and E. B. Gauda. 2011. Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants. J Pediatr. 158:57–64.
  • Clifford, M. 2000. Chlorogenic acid and other cinnamates-nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric. 80:1033–1043.
  • Correa, T. A., M. M. Rogero, B. M. Mioto, D. Tarasoutchi, V. L. Tuda, L. A. Cesar, and E. A. Torres. 2013. Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition. 29:977–981.
  • Cowan, T. E., M. S. A. Palmnäs, J. Yang, M. R. Bomhof, K. L. Ardell, R. A. Reimer, H. J. Vogel, and J. Shearer. 2013. Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics. Journal of Nutritional Biochemistry. 25:489–495.
  • Del Rio, D., A. Stalmach, L. Calani, and A. Crozier. Bioavailability of Coffee Chlorogenic Acids and Green Tea Flavan-3-ols. Nutrients. 2:820–833.
  • Ding, M., S. N. Bhupathiraju, M. Chen, R. M. van Dam, and F. B. Hu. 2014. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 37:569–586.
  • Eckel, R. H., S. M. Grundy, and P. Z. Zimmet. 2005. The metabolic syndrome. Lancet. 365:1415–1428.
  • Estruch, R., M. A. Martinez-Gonzalez, D. Corella, J. Salas-Salvado, V. Ruiz-Gutierrez, M. I. Covas, M. Fiol, E. Gomez-Gracia, M. C. Lopez-Sabater, E. Vinyoles, F. Aros, M. Conde, C. Lahoz, J. Lapetra, G. Saez, E. Ros, and P. S. Investigators. 2006. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 145:1–11.
  • Farah, A. 2012. Coffee Constituents. In Coffee: Emerging Health Effects and Disease Prevention., eds. Y.-F. Chu, 21–58. Oxford: Wiley-Blackwell.
  • Freedman, N. D., Y. Park, C. C. Abnet, A. R. Hollenbeck, and R. Sinha. 2012. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 366:1891–1904.
  • Furman, D., J. Chang, L. Lartigue, C. R. Bolen, F. Haddad, B. Gaudilliere, E. A. Ganio, G. K. Fragiadakis, M. H. Spitzer, I. Douchet, S. Daburon, J. F. Moreau, G. P. Nolan, P. Blanco, J. Dechanet-Merville, C. L. Dekker, V. Jojic, C. J. Kuo, M. M. Davis, and B. Faustin. 2017. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat Med. 23:174–184.
  • Gavrieli, A., M. Yannakoulia, E. Fragopoulou, D. Margaritopoulos, J. P. Chamberland, P. Kaisari, S. A. Kavouras, and C. S. Mantzoros. 2011. Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men. J Nutr. 141:703–707.
  • Giugliano, D., A. Ceriello, and K. Esposito. 2006. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 48:677–685.
  • Gómez-Ruiz, J. A., D. S. Leak, and J. M. Ames. 2007. In vitro antioxidant activity of coffee compounds and their metabolites. Journal of agricultural and food chemistry. 55:6962–6969.
  • Gouin, J. P., L. Hantsoo, and J. K. Kiecolt-Glaser. 2008. Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation. 15:251–259.
  • Greenberg, J. A., C. N. Boozer, and A. Geliebter. 2006. Coffee, diabetes, and weight control. Am J Clin Nutr. 84:682–693.
  • International Diabetes Federation (IDF). 2015. Diabetes.. 7 ed. Brussels, Belgium: International Diabetes Federation, http://www.diabetesatlas.org.
  • Jacobs, S., J. Kroger, A. Floegel, H. Boeing, D. Drogan, T. Pischon, A. Fritsche, C. Prehn, J. Adamski, B. Isermann, C. Weikert, and M. B. Schulze. 2014. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. Am J Clin Nutr. 100:891–900.
  • Jaquet, M., I. Rochat, J. Moulin, C. Cavin, and R. Bibiloni. 2009. Impact of coffee consumption on the gut microbiota: A human volunteer study. International Journal of Food Microbiology. 130:117–121.
  • Kempf, K., C. Herder, I. Erlund, H. Kolb, S. Martin, M. Carstensen, W. Koenig, J. Sundvall, S. Bidel, S. Kuha, and J. Tuomilehto. 2010. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 91:950–957.
  • Kempf, K., H. Kolb, B. Gartner, G. Bytof, H. Stiebitz, I. Lantz, R. Lang, T. Hofmann, and S. Martin. 2015. Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial. Eur J Nutr. 54:845–854.
  • Kleemola, P., P. Jousilahti, P. Pietinen, E. Vartiainen, and J. Tuomilehto. 2000. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med. 160:3393–3400.
  • Koloverou, E., D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, E. N. Georgousopoulou, A. Laskaris, C. Stefanadis, and A. S. group. 2015. The evaluation of inflammatory and oxidative stress biomarkers on coffee-diabetes association: results from the 10-year follow-up of the ATTICA Study (2002–2012). Eur J Clin Nutr. 69:1220–1225.
  • Koroglu, O. A., P. M. MacFarlane, K. V. Balan, W. J. Zenebe, A. Jafri, R. J. Martin, and P. Kc. 2014. Anti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitis. Neonatology. 106:235–240.
  • Kotani, K., K. Tsuzaki, Y. Sano, M. Maekawa, S. Fujiwara, T. Hamada, and N. Sakane. 2008. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med. 46:1434–1437.
  • Lang, R., E. F. Yagar, A. Wahl, A. Beusch, A. Dunkel, N. Dieminger, R. Eggers, G. Bytof, H. Stiebitz, I. Lantz, and T. Hofmann. 2013. Quantitative studies on roast kinetics for bioactives in coffee. J Agric Food Chem. 61:12123–12128.
  • Liberati, A., D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gotzsche, J. P. Ioannidis, M. Clarke, P. J. Devereaux, J. Kleijnen, and D. Moher. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 151:W65e94.
  • Lopez-Garcia, E., P. Guallar-Castillon, L. Leon-Munoz, A. Graciani, and F. Rodriguez-Artalejo. 2014. Coffee consumption and health-related quality of life. Clin Nutr. 33:143–149.
  • Lopez-Garcia, E., R. M. van Dam, L. Qi, and F. B. Hu. 2006. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 84:888–893.
  • McArdle, M. A., O. M. Finucane, R. M. Connaughton, A. M. McMorrow, and H. M. Roche. 2013. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 4:52.
  • Mejia, E. G., and M. V. Ramirez-Mares. 2014. Impact of caffeine and coffee on our health. Trends Endocrinol Metab. 25:489–492.
  • Muqaku, B., A. Tahir, P. Klepeisz, A. Bileck, D. Kreutz, R. L. Mayer, S. M. Meier, M. Gerner, K. Schmetterer, and C. Gerner. 2016. Coffee consumption modulates inflammatory processes in an individual fashion. Mol Nutr Food Res. 60:2529–2541.
  • Naidoo, N., C. Chen, S. A. Rebello, K. Speer, S. E. Tai, J. Lee, S. Buchmann, I. Koelling-Sperr, and R. M. Van Dam. 2011. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: A survey and cross sectional study. Nutrition Journal. 15:10–48.
  • Nordestgaard, A. T., M. Thomsen, and B. G. Nordestgaard. 2015. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol. 44:551–565.
  • Ohnaka, K., M. Ikeda, T. Maki, T. Okada, T. Shimazoe, M. Adachi, M. Nomura, R. Takayanagi, and S. Kono. 2012. Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab. 2012:207426.
  • Owoyele, B. V., A. L. Oyewole, S. A. Biliaminu, and Y. Alashi. 2015. Effect of taurine and caffeine on plasma c-reactive protein and calcium in Wistar rats. Afr J Med Med Sci. 44:229–236.
  • Palocz, O., E. Paszti-Gere, P. Galfi, and O. Farkas. 2016. Chlorogenic Acid Combined with Lactobacillus plantarum 2142 Reduced LPS-Induced Intestinal Inflammation and Oxidative Stress in IPEC-J2 Cells. PLoS One. 11:e0166642.
  • Preedy, V. R. E. 2015. Coffee in health and disease prevention., vol. 52, 467–478. London: Elsevier.
  • Ramakers, B. P., N. P. Riksen, P. van den Broek, B. Franke, W. H. Peters, J. G. van der Hoeven, P. Smits, and P. Pickkers. 2011. Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury. Crit Care. 15:R3.
  • Riedel, A. D. N., T. Bakuradze, R. Lang, G. A. M. Parra, C. M. Hochkogler, S. Winkler, G. Bytof, I. Lantz, H. Stiebitz, E. Richling, T. Hofmann, D. Marko, D. Schipp, J. Raedle, and V. Somoza. 2014. A 4-week consumption of medium roast and dark roast coffees affects parameters of energy status in healthy subjects. Food Research International. 63:409–419.
  • Saito, M., T. Nemoto, S. Tobimatsu, M. Ebata, Y. Le, and K. Nakajima. 2011. Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial. J Nutr Metab. 2011:146865.
  • Santos, R. M., and D. R. Lima. 2016. Coffee consumption, obesity and type 2 diabetes: a mini-review. Eur J Nutr. 55:1345–1358.
  • Sartorelli, D. S., G. Fagherazzi, B. Balkau, M. S. Touillaud, M. C. Boutron-Ruault, B. de Lauzon-Guillain, and F. Clavel-Chapelon. 2010. Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study. Am J Clin Nutr. 91:1002–1012.
  • Schauren, B. C., V. L. Portal, F. G. Beltrami, T. J. dos Santos, and L. C. Pellanda. 2014. Postprandial metabolism and inflammatory markers in overweight adolescents. J Dev Orig Health Dis. 5:299–306.
  • Schulze, M. B., K. Hoffmann, J. E. Manson, W. C. Willett, J. B. Meigs, C. Weikert, C. Heidemann, G. A. Colditz, and F. B. Hu. 2005. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 82:675–684; quiz 714–675.
  • Shang, F., X. Li, and X. Jiang. 2016. Coffee consumption and risk of the metabolic syndrome: A meta-analysis. Diabetes Metab. 42:80–87.
  • Shechter, M., G. Shalmon, M. Scheinowitz, N. Koren-Morag, M. S. Feinberg, D. Harats, B. A. Sela, Y. Sharabi, and P. Chouraqui. 2011. Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. Am J Cardiol. 107:1255–1261.
  • Stofkova, A. 2009. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul. 43:157–168.
  • Tauler, P., S. Martinez, P. Martinez, L. Lozano, C. Moreno, and A. Aguilo. 2016. Effects of Caffeine Supplementation on Plasma and Blood Mononuclear Cell Interleukin-10 Levels After Exercise. Int J Sport Nutr Exerc Metab. 26:8–16.
  • Tauler, P., S. Martinez, C. Moreno, M. Monjo, P. Martinez, and A. Aguilo. 2013. Effects of caffeine on the inflammatory response induced by a 15-km run competition. Med Sci Sports Exerc. 45:1269–1276.
  • Tharaheswari, M., N. Jayachandra Reddy, R. Kumar, K. C. Varshney, M. Kannan, and S. Sudha Rani. 2014. Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARgamma activity in type 2 diabetic rats. Mol Cell Biochem. 396:161–174.
  • Thomas, B. H., D. Ciliska, M. Dobbins, and S. Micucci. 2004. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs. 1:176–184.
  • Tunc, T., G. Aydemir, A. Karaoglu, F. Cekmez, M. Kul, S. Aydinoz, O. Babacan, H. Yaman, and S. U. Sarici. 2013. Toll-like receptor levels and caffeine responsiveness in rat pups during perinatal period. Regul Pept. 182:41–44.
  • Van Dam, R. M., and F. B. Hu. 2005. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 294:97–104.
  • Vinson, J. A., B. R. Burnham, and M. V. Nagendran. 2012. Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes. 5:21–27.
  • Walker, G. J., O. Finlay, H. Griffiths, J. Sylvester, M. Williams, and N. C. Bishop. 2007. Immunoendocrine response to cycling following ingestion of caffeine and carbohydrate. Med Sci Sports Exerc. 39:1554–1560.
  • Wedick, N. M., A. M. Brennan, Q. Sun, F. B. Hu, C. S. Mantzoros, and R. M. van Dam. 2011. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J. 10:93.
  • Williams, C. J., J. L. Fargnoli, J. J. Hwang, R. M. van Dam, G. L. Blackburn, F. B. Hu, and C. S. Mantzoros. 2008. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care. 31:504–507.
  • Yamashita, K., H. Yatsuya, T. Muramatsu, H. Toyoshima, T. Murohara, and K. Tamakoshi. 2012. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes. 2:e33.
  • Ye, H. Y., J. Jin, L. W. Jin, Y. Chen, Z. H. Zhou, and Z. Y. Li. 2017. Chlorogenic Acid Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting TLR4/NF-kappaB Signal Pathway. Inflammation. 40:523–529.
  • Zampelas, A., D. B. Panagiotakos, C. Pitsavos, C. Chrysohoou, and C. Stefanadis. 2004. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr. 80:862–867.
  • Zhang, W., E. Lopez-Garcia, T. Y. Li, F. B. Hu, and R. M. van Dam. 2009. Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes. Diabetes Care. 32:1043–1045.
  • Zhao, Y., K. Wu, J. Zheng, R. Zuo, and D. Li. 2015. Association of coffee drinking with all-cause mortality: a systematic review and meta-analysis. Public Health Nutr. 18:1282–1291.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.